GlassScriptPhysician profile
Tamara Joy Johnson
NPI 1891750758
$163.08
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $31.47 · 2022: $14.84.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $51.76 | 2019-2020 | |
| Kaleo, INC. | $19.52 | 2019 | |
| Cranial Technologies, INC | $18.80 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.97 | 2019 | |
| Pierre Fabre Pharmaceuticals, INC. | $14.84 | 2022 | |
| Shire North American Group INC | $13.91 | 2019 | |
| Ironshore Pharmaceuticals INC. | $13.18 | 2019 | |
| Tris Pharma INC | $13.18 | 2020 | |
| Travere Therapeutics, INC. | $1.92 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.